KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Dividends payables (2016 - 2026)

National Health Investors filings provide 18 years of Dividends payables readings, the most recent being $44.6 million for Q1 2026.

  • On a quarterly basis, Dividends payables rose 6.15% to $44.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $44.6 million, a 6.15% increase, with the full-year FY2025 number at $44.4 million, up 8.07% from a year prior.
  • Dividends payables hit $44.6 million in Q1 2026 for National Health Investors, roughly flat from $44.4 million in the prior quarter.
  • In the past five years, Dividends payables ranged from a high of $44.6 million in Q1 2026 to a low of $39.0 million in Q3 2022.
  • Median Dividends payables over the past 5 years was $39.3 million (2024), compared with a mean of $40.7 million.
  • Biggest five-year swings in Dividends payables: decreased 18.37% in 2022 and later grew 11.63% in 2025.
  • National Health Investors' Dividends payables stood at $39.0 million in 2022, then rose by 0.05% to $39.1 million in 2023, then grew by 5.25% to $41.1 million in 2024, then grew by 8.07% to $44.4 million in 2025, then grew by 0.38% to $44.6 million in 2026.
  • The last three reported values for Dividends payables were $44.6 million (Q1 2026), $44.4 million (Q4 2025), and $43.8 million (Q3 2025) per Business Quant data.